This inventor holds 1 USPTO granted patent. Top assignee: Elbion Ag. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Norbert Hofgen: Innovator in Phosphodiesterase Inhibition
Introduction
Norbert Hofgen is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors of phosphodiesterase 4.
Latest Patents
Hofgen holds a patent for "Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation." This patent highlights his innovative approach to creating therapeutic agents that can potentially treat various diseases.
Career Highlights
He is currently associated with Elbion AG, a company focused on developing novel therapeutic solutions. His work at Elbion AG has positioned him as a key player in the pharmaceutical industry.
Collaborations
Hofgen has collaborated with esteemed colleagues, including Ute Egerland and Hildegard Kuss, to advance research and development in his field.
Conclusion
Norbert Hofgen's contributions to the field of phosphodiesterase inhibition exemplify the impact of innovative thinking in medicinal chemistry. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile